NASDAQ NMS - GLOBAL MARKET · ASMB
-1.69% · -$0.4700 · Vol 170.0K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Assembly Biosciences Inc

Assembly Biosciences Inc

Biotechnology
$27.40

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is ASMB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ASMB are being assembled.
About Assembly Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2010
Employees
73
Country
US

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$27.86
Day high
$27.99
Day low
$26.45
Previous close
$27.87
52W high
$27.99
-2.11% from high
52W low
$26.45
62% of range
Market cap
$552.3M
EPS
$-3.7600
Shares out
19.8M
Volume
170K
VWAP
$27.05
Price history computed in-house
SMA 50 $27.40 · above
SMA 200 $27.40 · above
52W position 62%
Veridion warehouse edge

Warehouse intelligence for ASMB.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ASMB insider activity

Assembly Biosciences Inc

Score
Coverage building
Pressure
Net buying
Filings
6
Buys / sells
1 / 5
Net value
$12.5M
Insiders
3
Named filers
BM
Bjorkquist Jeanette M
Insider
Leadership
GI
GILEAD SCIENCES, INC.
Insider
Leadership
WS
White Nicole S
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $12.5M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-182026-06-17Bjorkquist Jeanette MInsidersell$23.252914,560$674SEC Form 4
2026-05-272026-05-26GILEAD SCIENCES, INC.Insiderbuy$26.50471,6984,977,089$12.5MSEC Form 4
2026-03-312026-03-30Bjorkquist Jeanette MInsidersell$27.491611,089$440SEC Form 4
2026-03-312026-03-30Bjorkquist Jeanette MInsidersell$26.6531211,105$8KSEC Form 4
2026-03-312026-03-30White Nicole SInsidersell$27.49937,477$247SEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 1 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ASMB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ASMB in this window.
Lobbying spend

ASMB lobbying filings, year to date.

Registered lobbying filings matched to Assembly Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ASMB in this window.
Latest news · ASMB
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ASMB.
Options
Sovereign unlock shows live options positioning for ASMB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.